Shanghai ZJ Bio-Tech Co

Shanghai ZJ Bio-Tech Co Assets per Share

The Total Assets per Share of Shanghai ZJ Bio-Tech Co (688317.SS) as of Nov 5, 2026 is 19.59 CNY. In the previous year, Total Assets per Share was 19.72 CNY — a change of -0.69% (lower).

Assets per Share

19.59CNY

YoY

-0.69%

Last updated:

Total Assets per Share of Shanghai ZJ Bio-Tech Co is 2025 19.59 CNY. Total Assets per Share of Shanghai ZJ Bio-Tech Co was 2024 19.72 CNY. It decreases by -0.69% lower compared to the previous year.

The Shanghai ZJ Bio-Tech Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
3.02 CNY
Jan 1, 2019
3.34 CNY
Jan 1, 2020
9.78 CNY
Jan 1, 2021
22.14 CNY
Jan 1, 2022
24.69 CNY
Jan 1, 2023
21.20 CNY
Jan 1, 2024
19.72 CNY
Jan 1, 2025
19.59 CNY
The Shanghai ZJ Bio-Tech Co Assets per Share history
YEARAssets per ShareYoY
19.59CNY-0.69%
19.72CNY-6.98%
21.20CNY-14.12%
24.69CNY+11.50%
22.14CNY+126.36%
9.78CNY+192.80%
3.34CNY+10.75%
3.02CNY+12.31%
2.69CNY-1.98%
2.74CNY+33.55%
2.05CNY+97.51%
1.04CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai ZJ Bio-Tech Co Stock analysis

What does Shanghai ZJ Bio-Tech Co do? Shanghai ZJ Bio-Tech Co., Ltd. generates revenue through the research, development, production, and sale of molecular diagnostic reagents and instruments. The company's primary products are nucleic acid detection kits and molecular diagnostic instruments, which are sold to customers in sectors including emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The firm focuses its business activities within the domestic market, targeting institutions and organizations requiring diagnostic solutions for public health and clinical applications. The company's business model centers on providing diagnostic reagents and equipment for critical applications such as emergency public health safety and medical clinical diagnosis. Its products are designed to meet the needs of domestic customers in healthcare, public safety, and food safety sectors, with a strong emphasis on molecular diagnostics. Shanghai ZJ Bio-Tech leverages its domestic market presence to serve institutions requiring reliable diagnostic tools for health and safety monitoring. Shanghai ZJ Bio-Tech Co., Ltd. operates with a domestic market focus, selling its molecular diagnostic instruments and reagents to entities involved in public health, clinical diagnosis, and food safety. The firm's revenue streams are derived from the sale of nucleic acid detection kits and molecular diagnostic instruments, which are essential for applications in emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. Shanghai ZJ Bio-Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai ZJ Bio-Tech Co stock

Total Assets per Share of Shanghai ZJ Bio-Tech Co is 19.59 CNY in 2025.

Total Assets per Share of Shanghai ZJ Bio-Tech Co changed from 19.72 CNY to 19.59 CNY, representing a -0.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Shanghai ZJ Bio-Tech Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Shanghai ZJ Bio-Tech Co

All Key Metrics — Shanghai ZJ Bio-Tech Co